Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease

Neuromodulation

Volumn 18, Issue 2, 2015, Pages 113-117

  Higuchi, Masa Aki ^a   Tsuboi, Yoshio ^a   Inoue, Tooru ^a   Fukuyama, Kouzou ^b   Abe, Hiroshi ^a   Baba, Yasuhiko ^b   Yamada, Tatsuo ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA WAJIRO HOSPITAL   (Japan)

Author keywords

Deep brain stimulation; movement disorders; outcomes; Parkinson's disease; psychological evaluation; subthalamic nucleus

Indexed keywords

ADULT; APATHY; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSKINESIA; FEMALE; HOEHN AND YAHR SCALE; HUMAN; MALE; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SELF-RATING DEPRESSION SCALE; SUBTHALAMIC NUCLEUS; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION; UNIFIED PARKINSON DISEASE RATING SCALE; ADVERSE EFFECTS; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; APATHY; DEEP BRAIN STIMULATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS;

EID: 84923591582     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12183     Document Type: Article

References (30)

1. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
2. Gronchi-Perrin A, Viollier S, Ghika J, et al. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease? Mov Disord 2006; 21: 1465-1468.
3. Haegelen C, Rouaud T, Darnault P, Morandi X,. The subthalamic nucleus is a key-structure of limbic basal ganglia functions. Med Hypotheses 2009; 72: 4121-4426.
4. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 565-567.
5. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI,. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588.
6. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641-1649.
7. Pluck GC, Brown RG,. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 636-642.
8. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function mood and behavior in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-839.
9. Czernecki V, Pillon B, Houeto JL, et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry 2005; 76: 775-779.
10. Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010; 133: 1111-1127.
11. Kirsch-Darrow L, Zahodne LB, Marsiske M, Okun MS, Foote KD, Bowers D,. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 182-188.
12. Gibb WR, Lees AJ,. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
13. Simonin C, Tir M, Devos D, et al. Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. J Neurol 2009; 256: 1736-1741.
14. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG,. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4: 134-139.
15. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000; 92: 615-625.
16. Houeto JL, Welter ML, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol 2003; 60: 690-694.
17. Hoehn MM, Yahr MD,. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
18. Fahn S, Elton R, Committee MotUD. Unified Parkinson's Disease Rating Scale. In:, Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information, 1987: 153-164.
19. Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N,. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the Short-Form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing 1995; 24: 505-509.
20. Zung WW,. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
21. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007; 22: 1077-1092.
22. Kenney C, Simpson R, Hunter C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007; 106: 621-625.
23. Drapier D, Drapier S, Sauleau P, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease? J Neurol 2006; 253: 1083-1091.
24. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B,. Motivation, reward and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002; 40: 2257-2267.
25. Poewe W, Antonini A, Zijlmans JC, Burkhard PR, Vingerhoets F,. Levodopa in the treatment of Parkinson's disease: an old drug still going strong. Clin Interv Aging 2010; 5: 229-238.
26. Voon V, Fernagut PO, Wickens J, et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesia to impulse control disorders. Lancet Neurol 2009; 8: 1140-1149.
27. Czernecki V, Schupbach M, Yaichi S, et al. Apathy following subthalamic stimulation in Parkinson's disease: a dopamine responsive syndrome. Mov Disord 2008; 23: 964-969.
28. Volkmann J,. Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiol 2004; 21: 6-17.
29. Martinez-Martin P, Valldeoriola F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002; 17: 372-377.
30. Leentjens AF, Dujardin K, Marsh L, et al. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 2004-2014.